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SUMMARY 
Disorders in wound healing (DWH) are severe post-surgical complications in trauma 
patients, unfortunately, the reasons being not completely understood. Wound related 
factors like infections, wound depth and localisation, as well as diabetes mellitus and 
vascular diseases may impair the tissue reformation. However, nutrition is hypothesised 
as an important factor for proper wound healing as micronutrients are directly involved in 
the healing process. The hypothesis of this thesis is that an inadequate status of 
antioxidant micronutrients may favour DWH. Reliable data on causal relationships, 
however, are lacking. 
Within a cross-sectional study (CHAPTER ONE) the plasma/serum status of 
vitamins A, C, D, E, and β-carotene, albumin, prealbumin were determined in 44 trauma 
patients with DWH (wound not closed or persisting secretion within 10 days post surgery 
or trauma) and in 45 trauma patients with regular wound healing (RWH). Moreover, 
markers indicating an imbalance between pro- and antioxidant status (malondialdehyde 
(MDA), peroxides, trolox equivalent antioxidant capacity (TEAC) as well as C-reactive 
protein (CRP) were assessed. Interestingly, Vitamin C, vitamin E/cholesterol-ratio, beta-
carotene, prealbumin, TEAC and peroxides were higher in patients with DWH than in 
patients with RWH. Most patients showed deficiencies in vitamin C, vitamin D, and 
β-carotene without differences between DWH and RWH. Only four patients with DWH 
and only one person with RWH had CRP concentrations within the reference range. 
Obviously, low values of several micronutrients are common in trauma patients with and 
without DWH and may be triggered by inflammation.  
In a placebo-controlled randomized trial (CHAPTER TWO), 20 trauma patients with 
DWH were recruited. The verum group (V) received an oral nutritional supplement 
(Glutamine Plus, Fresenius Kabi, Bad Homburg, Germany) for 14 days providing 500 
mg/d ascorbic acid, 166 mg/d α-tocopherol, 3.2 mg/d β-carotene, 100 µg/d selenium, 6.6 
mg/d zinc and 20 g/d glutamine; the placebo group (P) received isoenergetic amounts of 
maltodextrine instead. Before (d0) and after (d14) supplementation, plasma/serum levels 
of the ingested micronutrients, CRP and vascular endothelial growth factor-A (VEGF-A) 
were analysed and the microcirculation (O2-saturation, relative Hb, blood flow and 
velocity) of the wound was measured in 2 mm depth. The time to wound closing was 
recorded. At d0, the plasma status of micro-nutrients was comparable between the 
groups. No changes were observed in V and P, except for selenium which increased in 
V. Prevalence for hypovitaminosis did not change in any group. Glutamine decreased 
only in P. VEGF-A did not change in any group whereas CRP decreased in P. The O2-
saturation was lower in V than in P at d0. Except for the decrease in O2-saturation in P, 
the microcirculation did not change. The time to wound closing (no secretion/ 
inflammation/infection) was shorter in V than in P. The supplementation of antioxidant 
micronutrients and glutamine accelerates wound closing in trauma patients with DWH. 
Thus, the supplementation of antioxidative micronutrients and glutamine seems to be an 
effective dietary tool to improve wound healing. 
In conclusion, the results of the cross-sectional and interventional study do not 
show associations between the micronutrient concentrations in plasma/serum, 
parameters of oxidative stress and the wound healing of trauma patients with DWH. 
However, marker of the nutritional status in plasma/serum have to be evaluated 
cautiously due to post-traumatic inflammation which lowers micronutrient concentrations 
directly or indirectly by reduced availability of transporter proteins. Since the 
supplementation of micronutrients and glutamine accelerated WH, tailored nutritional 
measures contribute effectively to wound treatment and, thus, should be implemented in 
daily clinical routine.   
 
  
 
ZUSAMMENFASSUNG 
 
Wundheilungsstörungen (WHS) sind schwere postoperative Komplikationen bei 
unfallchirurgischen Patienten (UP), wobei die Ursachen noch nicht vollständig bekannt 
sind. Infektionen, Wundtiefe und -lokalisation betreffen die Wunde direkt und können 
ebenso wie Diabetes mellitus und vaskuläre Erkrankungen die Gewebeneubildung im 
Wundgebiet behindern. Es wird angenommen, dass die Ernährung ein wichtiger Faktor 
für eine regelgerechte Wundheilung (WH) ist, da Mikronährstoffe direkt am 
Heilungsprozess beteiligt sind. Die Hypothese dieser Dissertation ist, dass ein 
inadäquater Mikronährstoffstatus Störungen der Wundheilung begünstigen kann. 
Verlässliche Daten bezüglich der kausalen Zusammenhänge existieren bisher nicht. 
In einer Querschnittstudie (CHAPTER ONE) wurden bei 44 UP mit WHS (offene 
Wunde oder persistierende Sekretion 10 Tage nach Unfall oder Operation) und bei 45 
UP mit einer regelgerechten Wundheilung (RWH) die Plasma/Serum Konzentrationen 
(Konz.) von Vitamin A, C, D, E, β-Carotin, Albumin und Prealbumin bestimmt. Weiterhin 
wurden Malondialdehyd (MDA), Peroxide und trolox equivalent antioxidant capacity 
(TEAC), die ein Ungleichgewicht zwischen Pro- und Antioxidantien  angeben, sowie C-
reaktives Protein (CRP) analysiert. Die Konzentration von Vitamin C, Vitamin E/ 
Cholesterol Ratio, β-Carotin, Prealbumin, TEAC aber auch Peroxide waren höher bei 
Patienten mit WHS als mit RWH. Die meisten Patienten hatten einen Mangel an Vitamin 
C, Vitamin D und β-Carotin, wobei keine Unterschiede zwischen den Gruppen vorlagen. 
Bei nur vier Patienten mit WHS und einem mit RWH lagen die CRP Werte im 
Referenzbereich. Niedrige Mikronährstoffkonz. kommen bei UP mit WHS oder RWH 
offenbar häufig vor, wobei diese durch die Inflammation ausgelöst werden können.  
In einer Placebo-kontrollierten und randomisierten Studie (CHAPTER TWO) wurden 
20 UP mit WHS eingeschlossen. Patienten in der Verumgruppe (V) erhielten für 14 Tage 
ein orales Supplement (Glutamine Plus, Fresenius Kabi, Bad Homburg, Deutschland), 
das 500 mg/d Ascorbinsäure, 166 mg/d α-Tocopherol, 3,2 mg/d β-Carotin, 100 µg/d 
Selen, 6,6 mg/d Zink and 20 g/d Glutamin enthielt. Patienten der Plazebogruppe (P) 
wurden isoenergetische Mengen an Maltodextrin verabreicht. Vor (d0) und nach (d14) 
der Supplementation wurden die Plasma/Serum Konzentrationen der verabreichten 
Mikronährstoffe, CRP sowie vascular endothelial growth factor-A (VEGF-A) analysiert 
und die lokale Mikrozirkulation der Wunde (O2-Sättigung, relatives Hämoglobin, Blutfluss 
und Blutgeschwindigkeit) in 2 mm Gewebetiefe gemessen. Die Zeit bis zum 
Wundverschluss wurde erfasst. Zum Zeitpunkt d0 waren die Plasmakonzentrationen der 
Mikronährstoffe zwischen den Gruppen nicht verschieden und bis auf Selen (gestiegen) 
in V änderten sie sich nicht. Ebenfall blieb die Anzahl der Patienten mit einer 
Hypovitaminose sowie VEGF-A in beiden Gruppen unverändert. Allerdings sanken die 
Glutamin- und CRP Spiegel in P. Die O2-Sättigung war zum Zeitpunkt d0 in V geringer 
als in P, wobei diese in P später sank. Andere Parameter der Mikrozirkulation 
veränderten sich nicht. Die Zeit bis zum Wundverschluss (keine Sekretion/ Inflammation/ 
Infektion) war kürzer in V als in P. Demnach scheint die Supplementation von antioxi-
dativen Mikronährstoffen und Glutamin eine effektive Ernährungsmaßnahme zur 
Verbesserung der Wundheilung zu sein. 
Zusammenfassend kann gesagt werden, dass die Ergebnisse der Querschnitt- 
und Interventionsstudie keine Assoziation zwischen der Mikronährstoffkonzentration im 
Plasma/Serum, den Parametern des oxidativen Stresses und der Wundheilung bei UP 
mit WHS zeigen. Marker des Ernährungsstatus im Plasma/Serum müssen vorsichtig 
bewertet werden, da die posttraumatische Inflammation die Mikronährstoffkonzen-
trationen direkt oder indirekt über eine verringerte Verfügbarkeit an Transportproteinen 
erniedrigt. Da die Supplementation von Mikronährstoffen und Glutamin die WH 
beschleunigen, trägt eine zugeschnittene ernährungstherapeutische Maßnahme effektiv 
zur Wundbehandlung bei und sollte demnach in die tägliche klinische Routine 
aufgenommen werden.  
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Disorders in wound healing (DWH) are severe post-surgical complications in trauma 
patients [1] and favour wound infections (approximately 130,000 per year in 
Germany) which essentially contribute to high morbidity and mortality rates, and 
prolong the length of hospital stay [2]. Thus, DWH represent a significant individual 
burden and a challenge for the health care system.  
Wound healing (WH) is generally divided into four phases with their specific 
physiological functions which overlap in time: ‘1) hemostasis (vascular constriction, 
platelet aggregation, degranulation, and fibrin formation), 2) inflammation (leucocyte 
infiltration and the differentiation to macrophages), 3) tissue formation 
(reepithelialization, angiogenesis, collagen synthesis, formation of the extracellular 
matrix), and finally 4) tissue remodelling (collagen remodelling and vascular 
maturation) [3, 4]’. For proper WH, this complex process must elapse precisely timed 
and in a regulated progression with an optimal intensity in each stage [4]. Several 
local and systemic factors are identified to impair WH, activate one another and thus, 
can lead to DWH (Table 1). In general, local factors characterize the wound directly 
(eg. infection, wound type, depth or localisation) whereas systemic factors address 
health/disease/nutritional status, age, and lifestyle of the patients.  
 
Table 1: Factors affecting wound healing (modified according to Guo and DiPietro 2010[4]) 
Local factors Systemic factors 
Type of wound/grade of soft tissue 
trauma 
Main diagnosis/severity of disease 
Wound depth  Diseases/cormorbidities: diabetes mellitus, keloids, fibrosis, 
hereditary healing disorders, skin diseases (e.g. atopic 
dermatitis), jaundice, uremia  
Wound localisation Medications: glucocorticoid steroids, non-steroidal anti-
inflammatory drugs, chemotherapy 
Wound contamination/infection  Immune-compromised conditions: cancer, radiation therapy, 
AIDS 
Necroses Nutritional status: mal-/undernutrition, overweight/obesity 
Vascular diseases Oxidative stress 
Tissue oxygenation Smoking, drug and alcohol abuse  
pH-value of the wound Age 
 
Below, commonly seen factors which impair WH are shortly introduced. A 
major challenge in the therapy of wounds is to inhibit and avoid tissue necrosis as it 
leads to infections. The higher the grade of the soft tissue trauma, depth of the 
wound, and the location of the injury in peripheral areas, the higher is the risk for 
infections. Local bacterial growth is favoured by local hypoxia and diminished supply 
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of needed nutrients and vice versa in terms of a vicious circle [1]. In general, 
vascularisation and proliferation of new cells are impaired by decreased 
microcirculation in the wound area, diminished local perfusion [5], and oxygenation 
of the tissue. Thus, local tissue hypoxia plays a major role in the development of 
DWH. Smoking and diabetes mellitus are both associated with tissue hypoxia that 
lead to impaired proliferation and tissue remodelling by reducing the synthesis of 
collagen and hydroxyproline in case of smoking. As a consequence, smoking post-
surgery is accompanied with DWH [6], limited elasticity of the wound [7] and 
formation of necroses [8, 9].  
Major complications in patients with diabetes mellitus are severe diabetic foot 
ulcers which may lead to minor amputations of the foot or even major amputation of 
the leg [10]. Constant hyperglycemia damages vessel epithelia and may finally 
induce local hypoxia by capillary stenosis and lead to neuropathy and an impaired 
function of leukocytes [11, 12]. Thus, the adjustment of blood glucose levels [13] and 
HbA1c-level [10] are crucial in the treatment of chronic wounds of patients with 
diabetes mellitus. In general, patients with a compromised or deranged immune 
system due to cancer, radiation therapy [14], HIV/AIDS [15], or drug abusus [16] are 
at high risk for DWH since leukocytes function and the whole immune system are 
severely impaired. However, acetylsalicylic acid and ibuprofen as nonsteroidal anti-
inflammatory drugs decrease collagen production probably by impaired prosta-
glandin metabolism [11, 14]. Indeed, cortisone is a very potent drug against 
excessive inflammation but may inhibit severely WH by impairing fibrogenesis, 
angiogenesis, collagen synthesis, wound contraction and migration of epithelial cells 
[14, 17, 18].  
As a further factor for DWH, age is commonly discussed since chronic 
wounds mainly occur in elderly patients. It is known that WH is altered in the elderly 
[19] but the recent consensus is that the wound closure is retarded ‘but the final 
result is qualitatively similar to that in young people’ [19]. Thomas [20] concluded that 
DWH in the elderly are more often related to age-related comorbidities like diabetes 
mellitus rather than to age alone. Thus, an effective treatment of DWH requires a 
detailed insight of the patients´ anamnesis, a comprehensive training of the 
physicians and a multilateral approach. 
Integral parts of the modern wound therapy are: 1) radical debridement as the 
most common surgical measurement to eliminate wound necroses and debris, 2) 
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wound adapted care giving with different types of dressings and disinfection, and 3) 
systemic and/or local antibiosis [21]. Recently, the negative pressure wound therapy 
and skin grafting are implemented frequently to treat severe and chronic wounds [22, 
23]. These techniques target local factors to revitalize the injured tissue and to 
minimize contamination and infections. In general, the treatment of diseases and 
comorbidities as well as the education about a detrimental life style is implemented 
in the therapy. 
As previously addressed, severe illness, comorbidities, medication and 
metabolic stress have a huge impact on WH but also on the nutritional status of the 
patients. Since side effects of trauma and therapy like vomiting, nausea and 
decreased appetite significantly affect the nutritional intake of inpatients. Also high 
weight loss due to related illnesses leads frequently to under- and malnutrition. In 
consequence, low energy, protein and micronutrient intake favour protein-energy 
malnutrition and micronutrient deprivation which are discussed to impair cellular repair 
function and reduce plasma concentrations of transport proteins for micronutrients. 
Thus, adequate supply of energy, protein and selected micronutrients such as 
ascorbic acid, retinol, zinc, selenium is discussed to support proper WH. This leads to 
the question whether specific dietary measures may improve the WH process. The 
first hints that inadequate nutrition impairs WH originated from sailors in the 18th and 
19th century. In 1740, a ship’s surgeon observed how old wounds “in the progress of 
the disease broke out afresh” and hypothesized that fresh fruits and vegetables would 
cure scurvy [24]. Sailors who obtained the fruits and vegetables recovered quickly 
from scurvy and previously unhealed sores, in contrast to those who did not [25]. 
Nowadays, scurvy is known to result from a severe deficiency of ascorbic acid which 
is essential for fibroblast maturation, angiogenesis, and collagen synthesis [26]. WH is 
a complex process involving blood cells, extracellular matrix, and parenchymal cells 
[3, 27]. This process is orchestrated by enzymes and soluble mediators that usually 
depend on cofactors like vitamins or trace elements [28]. Retinol maintains the 
integrity of epithelial and mucosal surfaces and enhances fibroplasia that increases 
collagen synthesis and epithelialization [18, 29]. Zinc, a cofactor for enzymes like 
matrix metalloproteinases, is required for cell division, differentiation, growth as well 
as cross-linking of collagen fibres [30, 31]. Furthermore, zinc is essential for retinol 
transport in blood and for the oxidation of retinol to retinal [29]. Glutamine, an 
essential amino acid in stress conditions, appears to play an important role in WH as 
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a major metabolic fuel for rapidly proliferating cells such as enterocytes, fibroblasts, 
lymphocytes, epithelial cells, and macrophages [32]. Macrophages release nitric 
oxide and oxygen radicals which are antimicrobial and exert oxidative stress. 
Reactive oxygen species (ROS) play an outstanding role in coagulation, inflammation, 
and reepitheliazation as second messengers for inducing vascular endothelial growth 
factors (VEGF) [33]. However, ROS may also impair WH. An overproduction of ROS 
may inactivate epidermal enzymatic antioxidants which prolongs the inflammatory 
phase and delays or even inhibits the transition to tissue formation. Thus, oxidative 
stress is assumed to contribute to DWH [33-35]. Micronutrients with antioxidant 
properties (e.g., ascorbic acid, α-tocopherol, β-carotene; zinc and selenium as 
cofactors for antioxidant enzymes) may reduce oxidative stress. Hence, they are 
discussed to enhance WH [36-39] in addition to their physiological role in WH.  
Although nutrition in general seems to be crucial for proper WH, an adequate 
nutritional therapy is often not implemented in the treatment of non-healing wounds 
in trauma patients. This situation may be due to a missing nutritional education of the 
physicians in the medical professional training and certainly a lack of well-designed 
studies in trauma patients with DWH and, thus, evidence for efficacy. Hence, 
knowledge about specific nutritional deficiencies is a prerequisite for investigating the 
efficacy of a tailored nutritional supplementation in these patients.  
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As a consequence of the lacking data, this thesis tries to answer the following 
questions: 
 
1) Is there a difference in nutritional status and parameters of pro-/ antioxidant 
balance between patients with regular and delayed wound healing?  
         
2) Is the prevalence of deficiencies in specific micronutrients between patients 
with regular and delayed wound healing different?    
 
3) Is it possible to prevent trauma patients with DWH from hypovitaminoses by 
administration of a supplement rich in antioxidant micronutrients (vitamin C, E, 
β-carotene, zinc, selenium) and glutamine?           
 
4) Does the ingestion of this supplement improve the wound healing in these 
patients?                  
 
5) Does the ingestion of this supplement influence parameters of oxidative stress 
in these patients?                  
 
To approach these goals, two clinical studies were performed: 
The cross-sectional study (CHAPTER ONE) aims to answer question 1) and 2) 
by investigating the nutritional status as well as parameters of pro-/ antioxidant 
balance in adult trauma patients with regular and delayed wound healing, 
respectively.  
 
In a randomised, placebo controlled and double-blinded clinical trial (CHAPTER 
TWO), the questions 3) to 5) are tried to be answered by investigating the effect of a 
daily ingestion of an oral supplement rich in antioxidant micronutrients (vitamin C, E, 
β-carotene, zinc, selenium) and glutamine for 14 days in adult trauma patients with 
DWH.  
 
 
  
  
 
 
 
 
 
 
CHAPTER ONE 
 
 
 
Extracellular micronutrient levels and markers of pro-/antioxidant 
status in trauma patients with wound healing disorders:  
a cross-sectional study 
 
 
 
 
 
 
 
 
 
 
 
 
Presented in part at: 
29th and 30th ESPEN Congress on Clinical Nutrition and Metabolism (European Society for Clinical 
Nutrition and Metabolism) in Prague, Czech Republic, 2007, and in Florence, Italy, 2008, and at 7th 
and 8th Congress “Nutrition 2008“ and “Nutrition 2009“ (German Society for Nutrition Medicine, 
Austrian Society for Clinical Nutrition, and Swiss Society for Clinical Nutrition) in Hamburg, Germany, 
2008, and in Zurich, Switzerland, 2009. 
 
 
 
  
 
 CHAPTER ONE  19
Abstract 
 
Background: Disorders in wound healing (DWH) are common in trauma patients, 
the reasons being not completely understood. Inadequate nutritional status may 
favour DWH. Reliable data, however, are lacking.  
Methods: Within a cross-sectional study, the plasma/serum status of vitamin A, C, 
D, E, β-carotene, albumin, prealbumin, C-reactive protein, and cholesterol was 
determined in 44 trauma patients with DWH and in 45 trauma patients with regular 
wound healing (RWH).  
Results: Vitamin C (23.1±15.9 vs. 16.3±12.8 µmol/l), vitamin E/cholesterol ratio 
(9.8±3.2 vs. 5.6±1.9 µmol/mmol), β-carotene (0.6±0.4 vs. 0.4±0.3 µmol/l), and 
prealbumin (24.8±8.2 vs. 21.3±8.1 mg/dl) were significantly higher in patients with 
DWH than in patients with RWH. Most patients showed levels of vitamin C 
(<25 µmol/l; 64 vs. 83%), vitamin D (<50 µmol/l; 59 vs. 70%), and β-carotene (<0.9 
µmol/l; 86 vs. 93%) below the reference range without differences between DWH 
and RWH. Only four patients with DWH and only one person with RWH had 
C-reactive protein concentrations within the reference range (0 to <3 mg/l). 
Conclusions: Trauma patients with RWH and DWH suffer frequently from protein 
malnutrition and reduced plasma concentrations of several micronutrients probably 
due to inflammation, increased requirement, and oxidative burden. Thus, adequate 
nutritional measures are recommended to trauma patients. 
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Introduction 
Disorders in wound healing (DWH) are frequently observed in post-surgical patients 
with vascular diseases and soft tissue trauma [1]. DWH are associated with a 
prolonged hospital stay and essentially contribute to high morbidity and mortality 
rates [2]. Thus, apart from the individual burden, DWH generate enormous costs in 
the health care system. 
The pathophysiological mechanisms leading to DWH are not completely 
understood. Recent studies in patients with pressure ulcers [3] now support the 
hypothesis that general protein/energy malnutrition can considerably increase the 
risk for DWH by several mechanisms. The lack of energy and nitrogen containing 
metabolites like amino acids may hamper wound healing by diminishing the body’s 
capacity for cell repair. Low food/energy intake is often related to an insufficient 
provision of essential micronutrients. It is well-known that several vitamins and trace 
elements like retinol, ascorbic acid, 25-hydroxycholecalciferol (25(OH)D3), and zinc 
are involved in collagen synthesis, cell division, and in epithelialization [4-7]. A 
nutritive intake below actual recommendations published for healthy subjects may, 
thus, increase the risk to develop DWH or even aggravate DWH already existing. 
Moreover, it is still under debate whether in trauma the metabolic needs for 
micronutrients are considerably higher compared to physiological conditions [3]. An 
insufficient intake of micronutrients may lead to intra-/extracellular deficiencies 
resulting in an imbalance between pro-/ and antioxidants which exerts cytotoxic 
effects and, consequently, may impair wound healing as shown in a small patient 
group for selenium [8]. Representative cross-sectional studies focusing on the 
assessment and evaluation of general and specific nutritional status in a variety of 
patients with DWH are, however, scarce.  
The aim of this cross-sectional study was, thus, to assess the general 
nutritional status, the micronutrient profile and the concentration of selected 
biomarkers of pro-/antioxidative balance in trauma patients with or without DWH 
within a routine clinical setting.  
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Materials and Methods 
Patients 
Following a mono-centre cross-sectional design, adult trauma patients were 
recruited within two time periods (May - December 2006 and October 2008 - January 
2009) at the Department of Orthopaedics and Trauma Surgery, University of Bonn. 
Exclusion criteria were defined as follows: parenteral and enteral nutrition, exclusive 
implant removal, pressure ulcers as primary diagnosis, HIV infection, chronic 
inflammatory bowel diseases, liver diseases, drug abuse, pregnancy, lactation, stay 
in the intensive care unit, and sepsis. After enrolment, data on main diagnosis, 
comorbidities, and on medication were obtained and the individual injury severity 
score [9] was determined. The time between trauma/surgery and enrolment was 
documented. Wound healing progress was then evaluated using clinical criteria: 
DWH was diagnosed if the wound was not closed or secretion persisted within ten 
days after surgery or trauma. All patients received hospital food provided by an 
external caterer. Patients were asked whether they supplemented vitamins, zinc 
and/or selenium. 
All patients provided written informed consent prior to enrolment. The study 
was conducted according to the Declaration of Helsinki, 2004, and was authorized 
by the local Ethics Committee (No. 029/06). 
 
Blood sampling 
At the day after enrolment, blood samples (EDTA-, lithium heparinized tubes and 
tubes without anticoagulant) were collected after an overnight fast. Plasma and 
serum were obtained within two hours by centrifugation at 2,000 x g, 4 °C for 10 min. 
EDTA-plasma for ascorbic acid analysis was stabilized with 0.75 M metaphosphoric 
acid, centrifuged at 13,000 x g and the supernatant was discarded. Heparinized 
plasma for malondialdehyde (MDA) was protected against lipid peroxidation by 
addition of 0.05% butylhydroxytoluol. All samples were stored at -80 °C until 
analysis. Laboratory parameters, except for those investigated routinely, were 
analyzed in duplicate.  
 
Clinical chemistry 
Leukocytes (flow cytometry, Sysmex, Norderstedt, Germany), C-reactive protein 
(CRP; nephelometry, Siemens Healthcare Diagnostics, Eschborn, Germany), and 
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cholesterol (polychromatic measurement, Siemens Healthcare Diagnostics, 
Eschborn, Germany) were analyzed by routine clinical chemistry. The reference 
value for CRP was obtained from the Department of Clinical Chemistry and Clinical 
Pharmacology, University of Bonn.  
 
Anthropometric data and nutritional status 
Body mass index (BMI, kg/m2) was determined by weighing the patients and asking 
for their height and was evaluated according to the criteria of the International 
Obesity Task Force 1998 (underweight: <18.5; normal weight: 18.5 – 24.9; 
overweight: 25.0 – 29.9; obesity: ≥ 30.0). The calf and upper arm circumferences 
(cm) were measured in duplicate. Reference values for calf and upper arm 
circumferences (sex- and age-dependent) were taken from the NHANES study [10]; 
patients with values below the 10th percentile were categorized as malnourished 
(Table 2). The general nutritional status and the disease-associated weight loss were 
determined by the Subjective Global Assessment (SGA) [11]. Patients were 
classified as well-nourished (SGA A), moderately malnourished or suspected to be 
malnourished (SGA B) or severely malnourished (SGA C). 
Plasma concentrations of retinol (CV 4.3%), ascorbic acid (CV 3.2%), 
α-tocopherol (CV 4.1%), and β-carotene (CV 3.2%) were measured in EDTA-plasma 
by HPLC [12, 13]. 25(OH)D3 was analyzed by ELISA (CV 5.6% according to 
manufacturer; IDS, Frankfurt/Main, Germany). Vitamin E status was determined as 
α-tocopherol to cholesterol ratio. Zinc was measured in heparinized plasma by 
photometry (CV 1.9%; Wako Chemicals, Neuss, Germany) and selenium by atom 
absorption spectrometry (CV 3%; biosyn, Fellbach, Germany). Albumin was 
analyzed by routine clinical chemistry (Department of Clinical Chemistry and Clinical 
Pharmacology, University of Bonn). Prealbumin was determined by radial 
immunodiffusion (CV 0.7%; The Binding Site, Schwetzingen, Germany). Reference 
ranges published recently for retinol [14], ascorbic acid [14], α-tocopherol [15], 
β-carotene [14], albumin [16], and prealbumin [17] are included in Table 3 The 
reference ranges for zinc and selenium (Table 3) were obtained from the Department 
of Clinical Chemistry and Clinical Pharmacology, University of Bonn.  
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Markers of pro-/antioxidant balance  
The trolox equivalent antioxidant capacity (TEAC) assay [18] was used to determine 
antioxidant capacity (CV 1.2%) in EDTA-plasma. Malondialdehyde (MDA) [19] was 
measured in plasma by photometry (CV 7.4%). An ELISA kit was used to determine 
the concentration of peroxides (Dr. Franz Tatzber KEG, Bisamberg, Austria; CV 
4.3% according to the manufacturer) in EDTA-plasma. Uric acid was analyzed in 
serum by photometry (Siemens Healthcare Diagnostics, Eschborn, Germany). 
Normal values for TEAC, peroxides, and MDA were obtained by analyzing 
plasma/serum of healthy subjects from the staff (n = 19 - 89) (Table 4).  
 
 
Evaluation strategy and statistics 
The Student´s t-test was used to compare metric variables between patient groups 
with regular wound healing (RWH) and with DWH if data were normally distributed. 
The Mann-Whitney-U test was used instead if normal-distribution was either lacking 
or uncertain. For the comparison of nominal and ordinal variables between the 
groups, the χ2 -test and Fisher´s Exakt test were used. Correlations between CRP, 
albumin and prealbumin, and selected micronutrients were analyzed by the 
Pearson`s test. Statistical significance was assumed for P<0.05. PASW software, 
version 17.0 (SPSS Inc., Munich, Germany), was used for statistical evaluation. 
Results are presented as means ± SD and as median and quartiles, respectively.   
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Results 
Patients 
Within the two time periods, out of 89 patients fulfilling the inclusion criteria, 44 
showed DWH based on the predefined clinical criteria. The demographic data in 
DWH and RWH patients were comparable (Table 1). Compared with DWH, patients 
in the RWH group had more often soft tissue traumata (P<0.001). The time between 
trauma and study entry (P=0.003) and the length of hospital stay (P<0.001) was 
longer, and the prevalence for infections (P<0.001) and vascular diseases (P<0.001) 
was higher in patients with DWH than RWH (Table 1). Infections of osteosynthesis 
material occurred in five and methicillin-resistant Staphylococcus aureus infection in 
three patients with DWH, respectively. Two patients with DWH suffered from 
osteomyelitis.  
 
Clinical chemistry 
Leukocyte counts (DWH: 8.1  2.2 G/l vs. RWH: 7.3  2.4 G/l) and CRP 
concentrations (DWH: 21.2 [6.4; 88.7] mg/l vs. RWH: 42.4 [17.7; 83.1] mg/l) did not 
differ between the groups. Only four patients with DWH and one patient with RWH 
had CRP concentrations within the reference range (0 to <3 mg/l). Uric acid 
concentration was higher in patients with DWH (280 ± 85 µmol/l) than in patients with 
RWH (240 ± 91µmol/l; P=0.045). 
 
Body composition and nutritional status 
As shown in Table 2, BMI as well as calf and upper arm circumference were not 
different between the two groups. Five patients of both groups were underweight. 
Overweight was observed in 31% of the patients with DWH and in 48% with RWH, 
respectively, and 21% and 14% of the patients with DWH and RWH were obese. 
Values for calf circumference below the 10th percentile were noticed in 24% of the 
patients with DWH and in 14% of the patients with RWH, respectively. An upper arm 
circumference below the 10th percentile was identified in 19% of the patients with 
DWH and in 4% of those with RWH. In patients with DWH and RWH, the prevalence 
of general malnutrition (SGA B/C) was 55% and 49%, respectively. Significant 
weight loss (> 10% of weight within six months) was observed in 18% of the patients 
with DWH and in 2% of those with RWH (P=0.001). According to SGA classification, 
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15 (DWH) and 21 (RWH) patients were at risk for malnutrition; 9 patients with DWH 
were judged as severely malnourished (SGA C), and only one in RWH group.   
Patients with RWH had lower plasma concentrations of ascorbic acid 
(P=0.035), a lower -tocopherol/cholesterol ratio (P<0.001), and lower levels of 
-carotene (P=0.005) but higher concentrations of selenium (P<0.001) (Table 3). 
Prealbumin (P=0.047) was higher in patients with DWH than in RWH. The 
concentrations of retinol, 25(OH)D3, zinc and albumin were not different between the 
groups. However, as shown in Figure 1, the prevalence of micronutrient 
concentrations below the actual reference ranges was not different between patients 
with DWH and RWH except for selenium (P<0.001) where low values occurred more 
often in patients with DWH than RWH.  
The prevalence of low plasma values of pro-/vitamins, selenium, zinc, as well 
as albumin and prealbumin was not different between generally well-nourished 
(SGA A) and malnourished (SGA B/C) DWH and RWH patients (data not shown).  
As expected, there was an inverse correlation between CRP and albumin 
(r = -0.44, P<0.01) as well as between CRP and prealbumin (r = -0.486, P<0.01). 
Retinol (r = -0.533, P<0.001) ascorbic acid (r = -0.208, P<0.005), zinc (r = -0.567, 
P<0.001), and selenium (r = -0.371, P<0.01) were negatively correlated with CRP. 
 
Markers of pro-/antioxidant balance  
Results on TEAC, peroxides, and on MDA are shown in Table 4. TEAC and peroxides 
were lower in patients with RWH than with DWH (for both parameters, P<0.001). Due 
to technical problems, data on MDA of patients with RWH are lacking. Uric acid was 
even higher in patients with DWH (4.4 [3.8; 5.5]) than with RWH (3.7 [2.9; 4.7], 
P=0.017). In patients with either DWH (P=0.005) or RWH (P<0.001), TEAC as well as 
the concentration of peroxides (DWH: P<0.001; RWH: P<0.001) were lower than 
values known for healthy adults. MDA was higher in patients with DWH (P<0.001) 
compared to reference values. 
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Table 1:  Demographic and clinical data  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DWH: disorders in wound healing; RWH: regular wound healing; data: means ± SD; a median [quartiles]; 
b ingested by own decision; Group comparison: * χ2-test, # Student´s t-test; ~ Mann-Whitney-U test; n.s.: not 
significant 
 
 
 
 
 
 
 
 
 
 
 
DWH 
(n = 44) 
RWH 
(n = 45) P
 
Sex (male/female) [n] 29/15 23/22 n.s.* 
Age [years] 60 ± 21 62 ± 17 n.s.# 
Age (<65/≥65 years) [n] 22/22 22/23 n.s.* 
Period between trauma  
and study entry [d] a 26 [15; 68] 15 [12; 20] 0.003
~ 
Main diagnosis [n]   <0.001* 
   Spinal trauma – 5  
   Long bone fracture 10 22  
   Joint fracture 14 9  
   Hip/Pelvic fracture 6 3  
   Miscellaneous injuries 14 8  
Injury severity score 14 ± 8 10 ± 9 n.s.# 
Soft tissue trauma [n]    
   None 29 11 <0.001* 
   Grade I°/ II°/ III° 5/4/2 20/10/1  
Infections [n] 30 – <0.001* 
Comorbidities [n]    
   Vascular diseases 13 – <0.001* 
   Diabetes mellitus  7 4 n.s.* 
   Atopic dermatitis 3 1 n.s.* 
Cortisone intake [n] 7 2 n.s.* 
Current intake of supplements [n] 
(vitamins, minerals, combinations) b 4 29 <0.001* 
Smoker [n] 12 9 n.s.* 
Length of hospital stay [d] a 29 [21; 67] 15 [10; 21] <0.001~ 
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Table 2: Anthropometric data 
 
 
 
 
 
 
 
 
 
 
DWH: disorders in wound healing; RWH: regular wound healing; data: means  SD 
Differences between the groups were not detected (Student’s t-test). 
 
Table 3: Plasma protein and micronutrient concentrations  
 DWH (n = 44) 
RWH 
(n = 45) P
# Reference range 
Retinol [µmol/l] 1.4 ± 0.7 1.2 ± 0.5 n.s. 0.7 – 1.75 
Ascorbic acid [µmol/l] 23.1 ± 15.9 16.3 ± 12.8   0.035 25 – 85 
25(OH)D3 [nmol/l] 46.2 ± 30.6 44.6 ± 18.7 n.s. 50 – 175 
α-Tocopherol/cholesterol 
[µmol/mmol] 9.8 ± 3.2 5.6 ± 1.9 <0.001 > 2.2 
β-Carotene [µmol/l] 0.6 ± 0.4 0.4 ± 0.3   0.005 0.9 – 4.6 
Zinc [µmol/l] 12.4 ± 3.2 12.6 ± 3.7 n.s. 11.5 – 19.4 
Selenium [µmol/l] 0.79 ± 0.19 1.10 ± 0.24 <0.001 > 0.94 
Albumin [g/dl] 32.8 ± 8.5 32.1 ± 5.7 n.s. age-related $ 
Prealbumin [mg/dl] 24.8 ± 8.2 21.3 ± 8.1 0.047 15 – 36 
 
DWH: disorders in wound healing; RWH: regular wound healing; data: means  SD; 25(OH)D3: 25-
hydroxycholecalciferol; Reference range: $ albumin [g/l]: 35–53 (≤ 60 yrs), 34–48 (> 60 yrs), 33–47 (> 70 yrs), 
31–45 (> 80 yrs); Group comparison: # Student`s test; n.s.: not significant 
 
 
 
 
 
 
 
 
 DWH (n = 44) 
RWH 
(n = 45) Reference range
 
BMI [kg/m2] 25.5  5.3 25.7  6.6 18.5 – 24.9 
Calf circumference [cm] 34.8  5.1 36.0  4.7 > 10th percentile 
Upper arm circumference [cm] 30.5  4.9 31.6  3.7 > 10th percentile 
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Figure 1: Prevalence of micronutrients and plasma proteins concentrations below the 
reference range 
DWH (n = 44): disorders in wound healing; RWH (n = 45): regular wound healing; y: years; 25(OH)D3: 
25-hydroxycholecalciferol; Reference values: ascorbic acid: >28 µmol/l, retinol: 0.7 – 1.75 µmol/l, -carotene: 
>0.9 µmol/l, 25(OH)2D3: >50 nmol/l, -tocopherol/cholesterol >2.2 µmol/mmol, zinc: >11.2 µmol/l, selenium: 
>0.94 µmol/l, albumin [g/l]: 35–53 (≤ 60 yrs), 34–48 (> 60 yrs), 33–47 (> 70 yrs), 31–45 (> 80 yrs), prealbumin: 
>15 mg/dl; Group comparison: χ2-test. Nobody had an -tocopherol status below the reference range. 
 
 
 
 
Table 4: Markers of pro-/antioxidant balance  
 
 DWH  (n=44) 
RWH 
(n=45) P
# 
Reference  
range$ 
TEAC [mmol TE/l] 1.24 ± 0.16 1.06 ± 0.19 <0.001 1.60 ± 0.16 
Peroxides [mmol/l] 0.90 ± 0.27 0.48 ± 0.12 <0.001 0.72 ± 0.10 
MDA [µmol/l] 83.7 ± 33.5 – – 14.3 ± 4.1 
 
DWH: disorders in wound healing; RWH: regular wound healing; data: means  SD; TEAC: trolox equivalent 
antioxidant capacity; TE: trolox equivalents; MDA: malondialdehyde; $healthy controls (see text); Group 
comparison (DWH vs. RWH): # Student`s t-test 
 
 
 
 
 
 
 
 
 
% 
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Discussion 
To the best of our knowledge, this is the first cross-sectional study collecting various 
anthropometric, biochemical, and clinical data to evaluate the nutritional status and 
body composition in a great variety of post-surgical patients with vascular diseases 
and soft tissue trauma. The mono-centre study was performed within clinical routine 
ensuring that all patients received comparable medical therapy, care, and dietetic 
measures. Thus, a comparative evaluation of selected clinical and biochemical 
markers monitored in patients with and without DWH may provide hints for the failure 
of wound healing (WH).      
Interestingly, anthropometric data were not different between the groups; 
moreover, BMI as well as calf and upper arm circumferences were within the normal 
range (Table 2). Parameters of long-term (albumin) and short-term (prealbumin) 
protein status (Table 3, Figure 1) were in the lower normal range, but they were also 
comparable between the groups. Consequently, general protein/energy malnutrition 
which was proposed to favour DWH [3] cannot be seen as the decisive factor 
whether our post-surgical patients develop DWH or not. 
Although all patients exhibited an acceptable general nutrition status 
(Table 2), mean plasma concentrations of ascorbic acid, 25(OH)D3, and β-carotene 
(Table 3) were below the reference values and 60 to 90% of the patients had a 
deficiency in these micronutrients (Figure 1). Post-traumatic and post-surgical 
metabolic events like inflammation [20, 21] and oxidative stress [22] may generally 
contribute to the lower plasma levels of ascorbic acid and β-carotene. Since mean 
plasma concentrations of ascorbic acid and β-carotene were even slightly higher in 
patients with DWH compared with RWH, low plasma status of these nutrients may 
not be the reason to develop DWH. It should be, however, kept in mind that plasma 
levels provide no information with respect to substrate fluxes to the wound area. 
Independent whether DWH has developed or not, 30% of the patients exhibited an 
insufficient serum zinc status (Figure 1). Comparably low concentrations of zinc 
transporters like albumin and prealbumin (Table 3) can at least partly explain this 
observation. Another line of reasoning is the acute phase response (APR) itself [23, 
24]. Elevated concentrations of APR proteins like CRP and interleukin-6 are known 
to increase the expression of the zinc importer Zip14 [25] which leads to a fast zinc 
redistribution to organs [26]. Zorilla et al. [5, 27] showed that the serum zinc level is 
predictive for the WH process. Zorilla et al. [5, 27] determined the serum zinc level in 
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preoperative patients before elective hip replacement which may explain the different 
results obtained in our study (post-surgical analysis). In contrast to other 
micronutrients like retinol, ascorbic acid, and zinc, selenium has not a direct 
physiological function in WH. However, as a cofactor of glutathione peroxidase, 
selenium may reduce oxidative stress in patients with DWH [28]. Therefore, higher 
selenium concentrations in patients with RWH than in patients with DWH (Table 3) 
may partly explain beneficial WH. Insufficient serum 25(OH)D3 concentrations were 
observed in most of our patients in both groups (Figure 1). Since Miller et al. [29] 
observed an inverse association between serum vitamin D levels and inflammatory 
response following hip fracture, low 25(OH)D3 concentrations in our patients may 
result from APR-mediated inflammation. Moreover, immobilization of the patients 
may contribute to the low vitamin D status due to the lack of UV-induced 
endogenous synthesis.   
Disturbances in the redox state are discussed to be risk factors for delayed 
WH [8]. Since direct measurements of the short-lived reactive oxygen species 
require laborious and expensive techniques like electron paramagnetic resonance, 
indirect methods are used in routine clinical setting to detect an imbalance between 
pro- and antioxidants [30]. This includes the analysis of peroxidation products like 
MDA and peroxides, the analysis of single antioxidants (e.g., ascorbic acid, 
α-tocopherol, -carotene) [31], and of total antioxidant capacity which reflects the 
synergistic action between endogenous (albumin, uric acid) and nutritive (ascorbic 
acid, α-tocopherol, and -carotene) antioxidants [32]. Oxidative stress in patients 
with DWH was indicated by increased concentrations of peroxides and of MDA 
compared to the reference values for healthy adults. TEAC was higher in DWH than 
in RWH (Table 4) probably due to higher concentrations of uric acid.  
The strength of this study is the broad variety of biochemical, anthropometric, 
and clinical parameters which provides a detailed picture on the micronutrient status 
of trauma patients with DWH and RWH. Unfortunately, data on the quantity and 
quality of the diet considering energy, protein, and micronutrients of interest and data 
on the kind and dose of supplemented micronutrients were not collected. Hence, the 
impact of the nutritional intake on the nutritional status of our patients cannot be 
assessed. Moreover, vascular diseases and wound infections, known risk factors for 
DWH [1], were more prevalent in patients with DWH than with RWH (Table 1). As 
the period between trauma and study entry was shorter in RWH than in DWH 
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(Table 1) it cannot be completely excluded that the DWH and RWH patients were in 
different stages of inflammation even if CRP concentrations were comparable. 
In conclusion, trauma patients with RWH and DWH suffer frequently from 
protein malnutrition and reduced plasma concentrations of several micronutrients 
probably due to inflammation, increased requirement, and oxidative burden. Thus, 
tailored nutritional measures (fresh fruits, vegetables, and high quality protein) and/or 
an early supplementation with selected micronutrients are strongly recommended to 
all hospitalised trauma patients. 
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Abstract 
 
Background & aims: We hypothesize that wound closure in trauma patients with 
disorders in wound healing is accelerated by supplementation of antioxidant 
micronutrients and glutamine.  
Methods: In a randomized, double-blind, placebo-controlled trial, 20 trauma patients 
with disorders in wound healing were orally supplemented with antioxidant 
micronutrients (ascorbic acid, α-tocopherol, -carotene, zinc, selenium) and 
glutamine (verum) or they received isoenergetic amounts of maltodextrine (placebo) 
for 14 days. Plasma/serum levels of micronutrients, glutamine, and vascular 
endothelial growth factor-A (VEGF-A) were determined before and after 
supplementation. In the wound, several parameters of microcirculation were 
measured. Time from study entry to wound closure was recorded.  
Results: Micronutrients in plasma/serum did not change except for selenium which 
increased in the verum group (1.1±0.2 vs. 1.4±0.2 µmol/l; P=0.009). Glutamine 
decreased only in the placebo group (562±68 vs. 526±55 µmol/l; P=0.047). The 
prevalence of hypovitaminoses and the concentration of VEGF-A did not change. 
Considering microcirculation, only O2-saturation decreased in the placebo group 
(56.7±23.4 vs. 44.0±24.0 [arbitrary units]; P=0.043). Wound closure occurred more 
rapidly in the verum than in the placebo group (29 [22; 52] vs. 58 d [46; 92]; P=0.01). 
Conclusions: Time to wound closure can be shortened by oral antioxidant and 
glutamine containing supplements in trauma patients with disorders in wound 
healing. 
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Introduction 
Disorders in wound healing (DWH) are major complications in trauma patients 
associated with poor individual outcome. Dietary measures including micronutrient 
supplementation are discussed to improve the wound healing process [1,2], but 
clinical data on causal relationships are lacking.  
Antioxidant micronutrients, such as ascorbic acid, α-tocopherol and 
β-carotene, as well as cofactors of antioxidant enzymes, such as zinc and selenium, 
are attributed an important role in wound healing [2-4]. For example, ascorbic acid is 
mandatory for the formation of cross-links between collagen fibres, for fibroblast 
maturation, and for angiogenesis [2]. Retinol maintains the integrity of epithelial and 
mucosal surfaces and plays a role in fibroplasia [2,5]. Zinc is needed for the 
synthesis of the retinol binding protein which is required for retinol mobilization from 
hepatic stores [2,6] and for the formation of cross-links between collagen fibres [2]. 
Since injury generally leads to an increased formation of reactive oxygen 
species, an intra-/extracellular deficiency in these micronutrients resulting in 
oxidative stress may favour DWH [7]. Consequently, any measures to improve the 
antioxidative capacity in the injured body may be effective to avoid and/or treat 
DWH. In line with this hypothesis, adequate administration of antioxidant 
micronutrients like ascorbic acid and zinc has been proven to support regular wound 
healing in patients with pressure ulcer [8]. 
Glutamine is the major energy and nitrogen source for rapidly proliferating 
cells of the intestinal mucosa as well as for fibroblasts, epithelial cells, and 
leukocytes [9]. Any intra-/extracellular deprivation of this amino acid, frequently 
observed in catabolic [10] and post-traumatic [11] situations, may further enhance 
disturbances in wound healing.  
Based on these observations, we hypothesize that a daily oral 
supplementation with antioxidant micronutrients together with glutamine as energy 
and nitrogen donor prevents micronutrient and glutamine deprivation (primary aim) 
and, thus, improves wound healing (secondary aim) in trauma patients with DWH.  
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Materials and Methods 
Patients  
In this mono-centre PRCT, adult trauma patients with DWH (defined as failure to 
heal, i.e. wound not closed or persisting secretion within ten days after trauma or 
surgery) were consecutively recruited between October 2007 and November 2008 at 
the Department of Orthopaedics and Trauma Surgery, University Hospital of Bonn. 
Exclusion criteria were: prescribed parenteral and enteral nutrition, current 
supplementation with vitamins/trace elements (questionnaire) and consumption of 
juices fortified with vitamins, multiple trauma, exclusive implant removal, pressure 
ulcers as primary diagnosis, HIV infection, chronic inflammatory bowel diseases, 
liver disease, drug abuse, pregnancy, lactation, intensive care unit stay, and sepsis. 
Main diagnosis and co-morbidities were obtained from the patient files. The injury 
severity score was determined according to Baker et al. [12] All patients provided 
written, informed consent prior to enrolment. The study was conducted according to 
the Declaration of Helsinki 2004 and was authorized by the Ethics Committee of the 
University of Bonn (No. 123/07). 
 
Intervention 
Allocation to verum or placebo group was done by permuted-block randomization. 
Each block consisted of four patients (two patients per group) in a randomly selected 
order. Patients, physicians and nurses were blinded to treatment until data collection 
and analysis had been finalized. The patients assigned to the verum group were 
supplemented for fourteen days with two sachets of Glutamine Plus® granulate 
(Fresenius Kabi, Bad Homburg, Germany) twice daily (2 x 22.4 g) providing 500 mg 
ascorbic acid, 166 mg α-tocopherol, 3.2 mg -carotene, 100 µg selenium, 6.6 mg 
zinc, and 20 g glutamine in addition to their hospital diet. The placebo group received 
isoenergetic sachets containing only maltodextrine (a tasteless carbohydrate; Dr. 
Steidle, Linden, Germany) in a double-blind manner. The patients were instructed to 
mix the complete content of the sachets with yoghurt, dessert or beverage and to eat 
or drink the enriched food immediately. Additionally, patients were asked to 
document the intake of the supplement in a diary. 
All patients regularly received a protein-rich diet chosen from the diet 
catalogue provided by the hospital caterer. Juices fortified with vitamins and other 
micronutrients were excluded from the diet. Food intake was monitored on three 
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days during the study using a self-completed standardized dietary record. The intake 
of energy, protein, ascorbic acid, α-tocopherol, β-carotene, and zinc was calculated 
from the food records using commercial software (Ebis Pro 4.0, University of 
Hohenheim, Germany) based on the German Nutrient Data Base (Bundeslebens-
mittelschluessel, BLS) version II.3. 
 
Anthropometric data and general nutritional status  
Body composition and general nutritional status were determined on d0 and d14. 
Patients were weighed and asked for their heights; body mass index was then 
calculated (kg/m2) and classified (underweight: <18.5; normal weight: 18.5 - 24.9; 
overweight: 25.0 - 29.9; obesity: ≥ 30.0) [13].  
Calf and upper arm circumferences (cm) were measured twice and the triceps 
skin fold thickness (mm, GPM Switzerland) was measured in triplicate. General 
nutritional status and disease associated weight loss were determined by the 
Subjective Global Assessment (SGA) and classified as well-nourished (SGA A), 
moderately malnourished or suspected to be malnourished (SGA B), or severely 
malnourished (SGA C).[14] The risk for malnutrition (categories: no risk, at risk, at 
high risk) was estimated by the Nutritional Risk Screening-2002 [15]. 
 
Blood sampling 
After an overnight fast, blood was drawn before and after intervention (d0 and d14, 
respectively) using tubes coated with EDTA or lithium heparin and free of 
anticoagulant. Plasma was immediately obtained by centrifugation and stored at 
-80 °C until analysis. Preparation of plasma samples for analysis of ascorbic acid 
and glutamine was done as described earlier [16]. Heparinized plasma samples for 
malondialdehyde (MDA) and 8-isoprostane measurements were protected against 
lipid peroxidation by addition of 0.05% butylhydroxytoluol. All laboratory parameters, 
except for those investigated routinely, were analyzed in duplicate. 
 
Nutrient status  
The concentration of ascorbic acid in EDTA plasma was measured according to 
Steffan [17] (CV 3.2%). Retinol, -tocopherol, and -carotene were also determined 
by HPLC. The protocol of Erhardt et al. [18] was modified by using apocarotenal as 
internal standard, Nucleosil® 100-5 CN (Macherey-Nagel, Düren, Germany) as 
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column and a solution of 98% hexane and 2% isopropanol as mobile phase. Retinol 
was detected at 325 nm (CV 2.7%), -tocopherol at 292 nm (CV 4.1%) and 
-carotene at 450 nm (CV 3.5%). Vitamin E status is expressed as α-tocopherol to 
cholesterol ratio. 
Zinc was analyzed in heparinized plasma by photometry (CV 1.9%) and 
selenium by atom absorption spectrometry (CV 3%). Serum albumin was measured 
by nephelometry, prealbumin by radial immunodiffusion (CV 0.7%), and glutamine in 
heparinized plasma by HPLC using the OPA method (CV 1.5%) [19]. 
Reference ranges published recently for retinol [20], ascorbic acid [20], 
α-tocopherol [21], β-carotene [20], albumin [22], prealbumin [23], and glutamine [24] 
are included in Table 3. The reference ranges for zinc, selenium (Table 3), and uric 
acid (Table 5) were obtained from the Department of Clinical Chemistry and Clinical 
Pharmacology, University of Bonn.  
 
Metabolites and inflammatory markers 
Leukocytes (flow cytometry), cholesterol (polychromatic measurement), bone 
specific alkaline phosphatase (immunoassay), C-reactive protein (CRP; 
nephelometry), interleukin-6 and interleukin-8 (both immunoassay), transferrin 
(photometry), and ferritin (immunoassay) were analyzed at the Department of 
Clinical Chemistry and Clinical Pharmacology and evaluated using actual reference 
values (for details see Table 3).  
 
Markers of pro-/antioxidant balance  
Total antioxidant capacity of EDTA plasma was measured using the trolox equivalent 
antioxidant capacity (TEAC) assay [25] (CV 1.2%). Plasma malondialdehyde (MDA) 
was analyzed photometrically (CV 7.4%). ELISA kits were used to follow plasma 
concentrations of peroxides (Dr. Franz Tatzber KEG, Bisamberg, Austria; CV 4.3% 
according to the manufacturer) and total 8-isoprostanes (sum of free plus esterified 
8-isoprostanes) according to the procedure described previously by our group [16] 
(CV 10%). Uric acid was analysed photometrically within clinical routine and 
evaluated according to the reference range of the Department of Clinical Chemistry 
and Clinical Pharmacology, University of Bonn.  
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Wound healing 
Parameters of microcirculation at a tissue depth of 2 mm (oxygen saturation, relative 
haemoglobin, blood flow and velocity) were measured by a non-invasive technique 
combining white light spectroscopy with the measurement of laser-Doppler shift in 
one flat probe (O2C; Lea Medizintechnik, Giessen, Germany) on days 0, 7, and 14. 
The laser was placed for 30 seconds horizontally on the surface of the wound 
(proximal, distal, 4 - 6 points lateral/medial). For each parameter, the mean of all 
measured values was calculated. Investigations were always carried out by the 
same examiner. Reliability and validity of this method had been reported previously 
[26, 27].  
As an indicator of angiogenesis, vascular endothelial growth factor-A 
(VEGF-A) was determined in serum (ELISA; Quantikine, R&D Systems Europe, UK; 
CV 4.5% according to manufacturer). 
Wound temperature was measured on d0, d7 and d14 by digital thermograms 
using a sterling-cooled infrared scanning camera (VAIOSCAN 3201 ST, Jenoptic 
Laser, Jena, Germany; accuracy < ± 2K, resolution 0.03 K) and evaluated by the 
software IRBIS Plus V 2.2 (Infratec, Dresden, Germany). Clothes and bandages 
were removed 10 min before measurements. No disinfectants or further cooling 
solutions were used. 
Time to wound closure defined as the period between study entry and wound 
closure (criteria: completed medical treatment, no secretion, infection, and 
inflammation) was documented in the patient files or by inquiring from the 
subsequently medicating physician if wounds were closed after discharge.  
 
Statistics 
Statistical evaluation was performed with the PASW software, version 17.0 (SPSS 
Inc., Munich, Germany). Non-parametric tests were used to investigate differences 
between the groups (Mann-Whitney-U test) and within each group (Wilcoxon test). 
Nominal and ordinal variables were compared by χ2 -test and Fisher’s exakt test. 
Changes in the number of patients with nutrients below the reference range were 
analyzed with the McNemar test. Statistical significance was assumed for P ≤ 0.05. 
Metric data are presented as median and quartiles.  
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Calculation of sample size 
The calculation of the sample size was based on the assumption that the mean 
ascorbic acid concentration in plasma of 23 µmol/l (own results of a cross-sectional 
study with trauma patients suffering from disorders in wound healing) would increase 
to 50 µmol/l by supplementation of 500 mg/d ascorbic acid for 14 days. Considering 
a standard deviation of 16 µmol/l (own results from a cross-sectional study) and 
 = 0.05, an expected increase in ascorbic acid of 27 µmol/l would afford nine 
patients per group to achieve a power of 90%. Assuming a dropout rate of 10%, ten 
patients should be recruited for each group.       
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Results  
Twenty Caucasian trauma patients were included and finished the study per 
protocol. Demographic, anthropometric and clinical data (Table 1) as well as energy 
and nutrient intake from the daily hospital diet (Table 2) were comparable in the 
placebo and the verum group. Patients consumed 27 [24; 28] sachets in each group 
(compliance: 96%). 
Except for a lower α-tocopherol / cholesterol ratio in the placebo group (P=0.023), 
nutrient status was comparable in both groups at baseline (Table 3). In the verum 
group, only plasma concentrations of α-tocopherol (P=0.007) and selenium 
(P=0.009) increased and led to higher concentrations of α-tocopherol (P=0.005) and 
selenium (P=0.028) in the verum compared to the placebo group on d14. Albumin 
concentrations increased in both groups (verum: P=0.017; placebo: P=0.05). 
Glutamine decreased only in the placebo group (P=0.047) (Table 3). At baseline, 15 
out of 20 patients had ascorbic acid concentrations below the reference range 
(>25 µmol/l), whereas all patients had an adequate plasma status of α-tocopherol 
(>12 µmol/l, with an α-tocopherol/cholesterol ratio >2.2 µmol/mmol), and retinol 
concentrations higher than 0.7 µmol/l. Thirteen patients had low values of β-carotene 
(≤0.9 µmol/l) on d0 and low zinc and selenium concentrations occurred before 
intervention in four and two patients, respectively. The number of patients with 
concentrations below the reference values was not different between the groups at 
d0. The concentrations of ascorbic acid and β-carotene did not change in both 
groups. Statistical evaluation for zinc and selenium were not performed due to the 
low number of patients concerned. 
Metabolites and inflammatory markers (Table 4) did not differ on d0 except for 
cholesterol which was higher in the placebo group (P=0.026). In the placebo group, 
CRP (P=0.037) and interleukin-8 (P=0.033) decreased, while transferrin (P=0.028) 
increased during the study period. In the verum group, interleukin-6 (P=0.037) and 
ferritin (P=0.013) decreased, while transferrin (P=0.007) increased. Obviously, all 
patients of the verum group and 80% of the patients of the placebo group had CRP 
concentrations above the reference value before supplementation.  
TEAC, peroxides, MDA, and 8-isoprostanes did not differ on d0 and d14. 
8-isoprostanes decreased after supplementation with verum (P=0.028) (Table 5). 
Parameters on microcirculation of the wound and on VEGF-A concentrations 
are shown in Table 6. At baseline, O2-saturation (P=0.013) and blood flow (P=0.043) 
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significantly differed between the groups. O2-saturation diminished only in the 
placebo group (P=0.043). No further changes occurred. VEGF-A was always 
comparable in both groups and did not change. Wound temperature (°C) did not 
differ between groups and was not affected by intervention (d0: 34.2 [31.3; 34.8] vs. 
34.4 [32.0; 35.1]; d14: 33.9 [33.3; 34.5] vs. 34.2 [32.9; 34.6]). 
Most importantly, time to wound closure was shorter in the verum (29 days 
[22; 52]) than in the placebo group (58 days [46; 92]) (P = 0.01). However, length of 
hospital stay was not influenced (placebo: 25 days [9; 35]; verum: 31 days [24; 55]). 
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Table 1:  Demographic data, anthropometric, and clinical data at enrolment  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data: median [quartiles]; significant differences (P≤0.05) between the groups according to χ2-Test 
(nominal/ordinal data) and Mann-Whitney-U test (metric data) did not occur. BMI: body mass index; SGA: 
subjective global assessment; SGA A: well-nourished; SGA B: at risk for malnutrition or moderately 
malnourished; SGA C: severely malnourished; NRS: Nutritional Risk Screening. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Placebo 
(n=10) 
Verum 
(n=10) 
Sex  male/female 6/4 8/2 
Age [yrs]  45 [36; 76] 46 [27; 56] 
Age ≥ 65 years [n] 3 1 
Anthropometric data   
BMI (kg/m2) 27.6 [23.4; 30.7] 25.8 [23.4; 31.7] 
Triceps skin fold thickness (mm) 19.2 [11.8; 24.8] 16.1 [11.3; 21.9] 
Calf circumference (cm) 38.9 [33.8; 41.6] 37.6 [33.9; 42.1] 
Upper arm circumference (cm) 32.5 [29.2; 35.4] 31.3 [29.1; 36.4] 
Period between trauma and d0 [d]  30 [15; 70] 26 [12; 34] 
Main diagnosis [n]    
   Proximal tibia/ankle joint/foot trauma 9 6 
   Pelvic/hip trauma 1 4 
Injury severity score 9 [9; 21] 16 [9; 21] 
Soft tissue trauma [n]   
None/ grade I°/ II°- III° 3/2/5 5/3/2 
Infection [n] 4 4 
Comorbidities [n]   
   Vascular diseases - 1 
   Diabetes mellitus 1 1 
   Hypertension 2 3 
   Dementia 1 1 
   Decubitus ulcer 1 3 
Smoker [n] 5 4 
Length of hospital stay [d]  25 [9; 35] 31 [24; 55] 
SGA A/B/C (n) 6/2/2 3/5/2 
NRS no risk/risk/high risk (n) 6/2/2 3/4/3 
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Table 2:  Daily intake of energy and nutrients from food  
 
 
Placebo 
(n=10) 
Verum 
(n=10) 
Energy  
  (kJ) 
  (kcal) 
  (kJ/kg body weight) 
  (kcal/kg body weight) 
 
7477 [5498; 8259] 
1787 [1314; 1974] 
79.8 [67.3; 113.8] 
19.1 [16.1; 27.2] 
 
6799 [6335; 8506] 
1625 [1514; 2033] 
75.9 [61.6; 94.5] 
18.1 [14.7; 22.6] 
Protein [g] 67 [49; 83] 62 [47; 92] 
Protein [g/kg body weight] 0.7 [0.6; 1.1] 0.6 [0.5; 1.2] 
Ascorbic acid [mg] 45 [32; 60] 78 [48, 153] 
α-Tocopherol [mg α-tocopherol equivalent] 6 [5; 10] 8 [4; 9] 
β-Carotene [mg] 2 [1; 3] 2 [1; 3] 
Zinc [mg] 11 [7; 12] 8 [6; 12] 
 
Data: median [quartiles]; significant differences (P≤0.05) between the groups according to Mann-Whitney-U test 
did not occur
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Table 3: Nutrient status  
 
 
Placebo 
(n=10)  
Verum 
(n=10)  
Reference 
range 
 d0 d14 P d0 d14 P  
Ascorbic acid [µmol/l] 16.7 [9.5; 21.9] 40.8 [18.2; 50.9] n.s. 27.1 [13.1; 37.7] 35.8 [28.4; 50.1] n.s. 25 - 85 
α-Tocopherol [µmol/l] 33.6 [28.6; 34.8] 34.1 [27.9; 41.8]a n.s. 33.2 [25.8; 38.5] 46.8 [42.2; 65.0]a 0.007 12 - 50 
α-Tocopherol/cholesterol 
[µmol/mmol] 6.3 [5.8; 6.6]
b 6.4 [5.5; 6.9] n.s. 7.2 [6.5; 9.7]b 8.7 [8.2; 12.1] n.s. > 2.2 
β-Carotene [µmol/l] 0.6 [0.3; 0.9] 0.5 [0.3; 0.9] n.s. 0.5 [0.3; 1.3] 0.9 [0.5; 1.4] n.s. 0.9 - 4.6 
Retinol [µmol/l] 1.48 [1.29; 1.89] 1.82 [1.33; 2.12] n.s. 1.39 [0.99; 1.97] 1.52 [1.25; 1.89] n.s. 0.70 – 1.75 
Zinc [µmol/l] 13.2 [11.2; 14.6] 11.8 [10.0; 15.3] n.s. 13.4 [11.9; 17.5] 15.4 [13.2; 16.5] n.s. 11.5 - 19.4 
Selenium [µmol/l] 1.1 [0.9; 1.3] 1.1 [0.9; 1.3]c n.s. 1.0 [0.9; 1.1] 1.4 [1.2; 1.5]c 0.009 > 0.63 
Albumin [g/l] 33.3 [32.0; 36.1] 37.3 [32.1; 38.9] 0.05 32.3 [25.2; 34.9] 34.1 [31.4; 37.5] 0.017 age related $ 
Prealbumin [mg/dl] 23.9 [18.1; 30.8] 23.2 [19.7; 28.4] n.s. 23.2 [14.1; 27.5] 26.0 [21.2; 28.8] n.s. 15 - 36 
Glutamine [µmol/l] 551 [495; 636] 535 [468; 567] 0.047 536 [459; 593] 590 [505; 719] n.s. 655 ± 84 
 
Data: median [quartiles]; d0: baseline; d14: after 14-day supplementation; n.s.: not significant; $ Reference ranges for albumin [g/l]: 35-53 (≤ 60 yrs), 34-48 (> 60 yrs), 33-47 
(> 70 yrs), 31-45 (> 80 yrs); letters indicate significant differences (P≤0.05) between the groups according to Mann-Whitney-U test: a P=0.005, b P=0.023, c P=0.028; 
P: significant changes (P≤0.05)   within d0 and d14 according to Wilcoxon-test 
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Table 4: Metabolites and inflammatory markers 
 
 
Placebo 
(n=10)  
Verum 
(n=10)  
Reference 
range 
 d0 d14 P d0 d14 P  
Leukocytes [G/l] 7.9 [6.4; 9.4] 7.4 [6.4; 8.6] n.s. 7.1 [6.4; 8.8] 6.8 [5.3; 7.3] n.s. 3.5 - 9.8 
Cholesterol [mmol/l] 5.4 [4.7; 6.0]a 5.4 [6.9; 5.4] n.s. 4.4 [3.7; 5.1]a 5.3 [4.8; 5.5] 0.005 < 5.2 
Uric acid [µmol/l] 280 [196; 375] 292 [220; 386] n.s. 274 [161; 309] 321 [220; 369] n.s. 214-446 (m) 137-157 (f) 
Bone specific alkaline 
phosphatase [µg/l] 
16.1 [12.1; 22.6] 15.9 [13.5; 24.6] n.s. 11.9 [7.9; 25.5] 13.3 [9.4; 31.4] n.s. 7 - 20 
C-reactive protein [mg/l] 9.8 [5.2; 29.0] 6.4 [3.5; 8.5] 0.037 25.3 [9.7; 73.6] 10.7 [5.9; 21.9] n.s. < 3 
Interleukin-6 [pg/ml]  3.3 [2.0; 8.6] 3.6 [2.2; 4.9] n.s. 10.2 [2.5; 19.6] 4.9 [2.0; 7.9] 0.037 < 5 
Interleukin-8 [pg/ml]  9.5 [6.2; 12.9] 6.8 [5.5; 11.7] 0.033 10.4 [5.1; 18.6] 6.9 [5.1; 15.2] n.s. < 15 
Transferrin [g/l] 2.7 [1.9; 3.3] 2.9 [2.2; 3.2] 0.028 2.2 [1.9; 2.5] 2.4 [2.2; 2.8] 0.007 2 – 3.6 
Ferritin [µg/l]  98.4 [27.1; 168.4] 56.1 [22.2; 193.8] n.s. 167.8 [117.3; 444.0] 92.2 [55.7; 368.3] 0.013 26 - 388 (m) 13 - 252 (f) 
 
Data: median [quartiles]; d0: baseline; d14: after 14-day supplementation; n.s.: not significant; letters indicate significant differences (P≤0.05) between the groups according 
to Mann-Whitney-U test: a P=0.026; P: significant changes within the groups between d0 and d14 according to Wilcoxon-test 
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Table 5: Markers of pro-/antioxidant balance  
 
 
Placebo 
(n=10)  
Verum 
(n=10)  
 d0 d14 P d0 d14 P 
TEAC [mmol TE/l] 1.02 [0.96; 1.07] 1.04 [0.95; 1.07] n.s. 1.04 [1.01; 1.06] 1.00 [0.96; 1.12] n.s. 
Peroxides [mmol/l] 0.42 [0.37; 0.56] 0.41 [0.34; 0.55] n.s. 0.49 [0.29; 0.64] 0.46 [0.36; 0.53] n.s. 
MDA [µmol/l] 199.3 [163.0; 222.3] 174.6 [155.7; 199.3] n.s. 174.3 [147.6; 194.2] 170.3 [138.6; 187.7] n.s. 
8-Isoprostane  [pg/ml] 14.9 [9.8; 21.5] 19.8 [11.4; 26.3] n.s. 20.6 [18.3; 23.5] 13.3 [9.6; 16.9] 0.028 
 
Data: median [quartiles]; d0: baseline; d14: after 14-day supplementation; TEAC: trolox equivalent antioxidant capacity; TE: trolox equivalents; MDA: malondialdehyde; 
significant differences (P≤0.05) between the groups according to Mann-Whitney-U test did not occur; P: changes within the groups analysed by Wilcoxon-test 
 
 
 
 
Table 6: Parameters on microcirculation and vascular endothelial growth factor 
 
 
Placebo 
(n=10)  
Verum 
(n=10)  
 d0 d14 P d0 d14 P 
O2-saturation  67 [28; 73]a 53 [19; 65] 0.043 19 [14; 35]a 44 [23; 65] n.s. 
Relative haemoglobin 48 [24; 56] 55 [33; 91] n.s. 51 [28; 62] 43 [12; 64] n.s. 
Blood flow 80 [24; 93]b 40 [30; 78] n.s. 32 [20; 43]b 44 [28; 104] n.s. 
Blood velocity 17 [14; 19] 16 [14; 17] n.s. 14 [12; 17] 14 [13; 17] n.s. 
VEGF-A [pg/ml]  695 [415; 879] 553 [289; 749] n.s. 551 [318; 1019] 539 [290; 910] n.s. 
 
Data: median [quartiles] in arbitrary units if not indicated otherwise; d0: baseline; d14: after 14-day supplementation; VEGF-A: vascular endothelial growth factor A; letters indicate 
significant differences (P≤0.05) between the groups according to Mann-Whitney-U test: a P=0.013, b P=0.043; P: significant changes within d0 and d14 according to Wilcoxon test. 
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Figure 1: Time to wound closure 
 
Group comparison: done according to Mann-Whitney-U test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P=0.01 
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Discussion 
In line with our working hypothesis, our study could demonstrate that a high-dose 
oral supplementation with antioxidant micronutrients together with glutamine is an 
effective therapeutic measure in hospitalized trauma patients with DWH. After 14 
days of intervention, time to wound closure was significantly shorter in the verum 
compared to the placebo group (Figure 1). This clinically relevant observation was, 
however, not associated with a reduction in the length of hospital stay. Since 
pelvic/hip fractures are commonly associated with a longer hospital stay and a higher 
injury severity score, the higher percentage of patients with pelvic/hip fractures in the 
verum group compared to the placebo group may partly explain this result. 
Anthropometric and clinical characteristics (Table 1) as well as nutrient intake by 
hospital food (Table 2) and nutritional status (Table 3) did not differ between groups. 
Due to similar medical treatment, accelerated wound healing, thus, seems to be 
related to the additional intake of micronutrients and glutamine by the oral nutritional 
supplement (ONS). 
The mechanisms behind this effect are, however, still unknown. Generally, 
low plasma concentrations of ascorbic acid, -carotene, zinc, and albumin (Table 3) 
suggest a poor specific nutritional status, thereby confirming earlier results of a 
cross-sectional study in this patient group [28, 29]. Only the plasma status for 
selenium improved during intervention (Table 3); in addition, the number of patients 
with micronutrient concentrations below the reference range remained unchanged. 
Thus, changes in plasma concentrations of micronutrients cannot explain the 
accelerated WH observed.  
A common phenomenon in patients with DWH is the acute phase response 
(APR) [2,30-32] resulting in elevated levels of inflammatory markers like CRP, as 
also measured in our study (Table 4). APR is known to reduce the synthesis of 
albumin and prealbumin which are transporters of several circulating micronutrients 
[2,33-35]. Thus, inflammation per se may reduce micronutrients in plasma/serum [2, 
36-38]. In line with this assumption, we observed low levels of albumin and 
prealbumin which may explain the reduced levels of β-carotene and zinc. As 
suggested by Wilson et al. [39] and Fukushima and Yamazaki [40], APR may also 
account for the lacking increase in plasma ascorbic acid (Table 3). Micronutrients 
ingested may have accumulated in the wound area where the metabolic 
requirements for cell growth and differentiation are probably increased. Such an 
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effect has previously been reported for zinc [41]. Under conditions of inflammation 
and infection, zinc was redistributed to organs with higher priority.  
Plasma glutamine concentrations (Table 3) were within the reference range 
(655 ± 84 µmol/l) [42] throughout the study. Despite normal plasma levels, 
intracellular deprivation may occur [43]. Thus, it can be speculated that 
supplementation of glutamine by our ONS did not only maintain plasma glutamine 
level (Table 3), but also increased intracellular glutamine availability, thereby 
supporting healing processes. Campos et al. [44] suggested that glutamine improves 
the cellular utilization of L-ascorbate by Escherichia coli. If this also applies to human 
cells, this mechanism may contribute to accelerated wound healing in our verum 
group (Figure 1) indicating a beneficial effect of glutamine supplementation in 
patients with DWH. 
An imbalance between pro- and antioxidants, the so called oxidative stress, is 
suggested to favour cell damage [45] and to enhance inflammatory processes [46].  
Indeed, biomarkers of pro-/antioxidant balance (Table 5) indicate a low level of 
antioxidant protection in our patients. TEAC reached only 60% of values determined 
previously for young healthy adults by our group [47], and 8-isoprostane levels were 
twice as high compared to normal [47]. The concentration of MDA in young healthy 
subjects was 14.3 ± 4.1 µmol/l (unpublished data from our laboratory), and thus, far 
lower than in the present study (Table 5). Only a decrease in 8-isoprostanes, a 
marker of lipid peroxidation, may be explained by the increase in α-tocopherol 
(Table 3). The lack of similar changes in MDA (Table 5) is not a contradiction as 
MDA - in contrast to 8-isoprostane - is not a specific product of lipid peroxidation 
[48]. In the verum group, peroxides did not change (Table 5) despite an increase of 
selenium (Table 3), the cofactor of glutathione peroxidase. Since correlations 
between the selenium concentration in serum and the activity of glutathione 
peroxidase in plasma occur only for selenium concentrations <0.63 µmol/l [49], an 
increase in glutathione peroxidase activity in the verum group is unlikely. As 
oxidative stress is discussed to impair wound healing [7], the reduction of oxidative 
stress indicated by reduced concentrations of 8-isoprostanes (Table 5) may also 
have favoured wound healing in the verum group.  
Parameters of microcirculation measured directly by O2C are suggested as 
reliable measures predicting the course of wound healing processes [26, 27].  
Unfortunately, O2 saturation and blood flow were different between groups on d0 
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(Table 6). Thus, the impact of the intervention on microcirculation can not be reliably 
evaluated. A major problem in this respect is the standardization of the 
measurement. Wound location, wound size, and micro-movements during 
measurement often lead to non reproducible results. 
VEGF-A, mainly produced by macrophages, muscle cells, and fibroblasts in the 
wounded tissue, is an indicator for angiogenesis and induces post-traumatic 
formation of new vessels [50]. In our patients, the concentration of VEGF-A in serum 
did not differ between the groups at any time and no changes occurred (Table 6). 
Since VEGF-A levels in serum and plasma were much lower than in the wound fluid 
[51] and the fracture haematoma [52], serum levels as measured in our study did not 
correctly mirror the situation in the wounded tissue. Analyses in the wound would 
have been desirable. However, this was not possible for ethical/medical reasons.     
In trauma patients with DWH, inflammation and/or infection are associated 
with hyperemia. Thus, a decrease in wound temperature is expected to occur during 
wound healing. In our study, wound temperature was measured by thermography 
which reflects local blood flow [53]. Indeed, the maximum temperature was higher in 
the wounded area of the injured extremity than in the corresponding area of the non-
injured extremity (34°C and 28 - 30°C, respectively). However, the temperature did 
not change over time in either group. Keeping in mind that the wounds of our 
patients were closed 29 and 58 days after onset of intervention, no changes in 
wound temperature on d14 may be expected.  
In conclusion, our randomized and controlled study demonstrates for the first 
time that the supplementation of antioxidant micronutrients and glutamine is 
associated with an accelerated wound closure in patients with DWH. The underlying 
mechanism(s) remain debatable.   
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The aim of this thesis was the assessment and evaluation of the nutritional status of 
trauma patients with DWH and its relation to WH. To clarify the impact of the 
nutritional status on WH, two studies were conducted. The cross-sectional study 
(CHAPTER ONE) addressed the question if the nutritional status is different compared 
to trauma patients with RWH. Then, the aim of the interventional study (CHAPTER 
TWO) was to investigate if the status of specific micronutrients and the wound healing 
can be enhanced in trauma patients with DWH by an oral supplementation with 
these micronutrients and glutamine. 
Surprisingly, the general nutritional status and the prevalence of micronutrient 
concentrations in plasma below the reference range were not different between 
patients with RWH and DWH. The concentrations of ascorbic acid, β-carotene as 
well as the α-tocopherol/cholesterol ratio were even lower in patients with RWH (see 
CHAPTER ONE Table 3 and Figure 1). Nevertheless, it is hypothesised that the poor 
status of several micronutrients in acute trauma patients with DWH is associated 
with DWH. Consequently, meeting the increased requirement by metabolic changes 
as well as loss of blood and wound fluid may probably not be achieved by a normal 
diet. Hence, we assumed that an oral supplementation with antioxidant 
micronutrients and glutamine enhances the nutritional status and, thus, WH in 
trauma patients with DWH. In fact, wound closure was faster in patients of the verum 
group even if the micronutrients, except for selenium, and glutamine in plasma did 
not change and were, thus, not different between the verum and the placebo group 
after intervention (see CHAPTER TWO Table 3, Table 4 and Figure 1). Hence, an 
association between the status of selected micronutrients in plasma/serum and WH 
was not verifiable in both studies (CHAPTER ONE and CHAPTER TWO).  
To explain this phenomenon, the inflammatory status of the trauma patients 
has to be considered. Nearly all patients, regardless the progress of WH, suffered 
from inflammation as concentrations of CRP, a reliable marker for the inflammatory 
status [1] were elevated (see CHAPTER ONE: results section and CHAPTER TWO: Table 
5). Maximum CRP concentrations are usually achieved two to five days after trauma 
or surgery and normalize within 30 days. However, in patients with post-surgical 
complications (e.g. infections or failed WH), CRP levels are permanently increased 
[2]. As discussed in CHAPTER ONE and TWO, inflammation has a major impact on the 
plasma nutrient status in injured patients e.g. by lowering the nutrients per se or 
reducing the transportation-proteins for several micronutrients. This relationship was 
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underlined by the inverse correlation between CRP and several micronutrients 
(ascorbic acid retinol, zinc, and selenium) as well as albumin and prealbumin 
(CHAPTER ONE, result section). This result is in line with findings of other studies [3, 
4]. An association between elevated CRP concentrations and plasma nutrients was 
observed by Gariballa et al. [4] in 445 elderly hospitalized patients with several 
diagnoses. Hereby, plasma vitamin C was 6.5 µmol/l lower in patients with elevated 
CRP levels (CRP concentrations > 10 mg/l) compared to patients with normal CRP 
concentrations. Inflammation explained most of the variance (P=0.011) for vitamin C 
concentrations in plasma. After adjusting for confounders (comorbidities, age, 
medication), inflammation was identified as an independent risk factor for poor 
nutritional status in plasma/serum which corroborates our observations in DWH 
patients (see CHAPTER ONE: Table 3, Figure 1 and CHAPTER TWO: Table 3, Table 4). 
Craig et al. [3] observed in geriatric patients with an acute illness a negative 
correlation (r=0.33, P<0.001) between serum zinc and CRP. This may be caused by 
acute infections, tissue injury and the elevated synthesis of CRP and IL-6 that 
increased the gene expression of the zinc importer Zip14 on hepatic cells [5]. Thus, 
the micronutrient und protein concentrations in plasma/serum depend on the 
inflammatory status.  
 In the interventional study (CHAPTER TWO), trauma patients with DWH were 
supplemented with moderate doses of micronutrients but an increase in plasma 
concentrations of micronutrients (except for selenium, P=0.009) was not observed. 
Nevertheless, wounds were closed faster in the verum than in the placebo group. 
Similar results were obtained by Desneves et al. [6] who investigated patients with 
pressure ulcers stage II-IV and non-acute wounds. The pressure ulcer scale for 
healing score [7] decreased in the verum group after three weeks of intervention but 
not in the control group even if the plasma concentrations of zinc and vitamin C did 
not change after a daily intake of an oral nutritional supplement providing 500 mg 
ascorbic acid, 7.5 mg zinc, 21 g protein, and 9 g arginine. In the study of Raffoul et 
al. [8] patients with lower limb and pressure ulcers received a tablet with several 
vitamins as well as minerals and additionally a tablet with 500 mg vitamin C for 15 
days. The time to wound closure in all supplemented patients was comparable to our 
patients (CHAPTER TWO) as well as the observation that the concentrations of 
ascorbic acid and further micronutrients in serum/plasma were not affected by 
intervention. In other studies [9-11], complete wound closure was also achieved after 
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a supplementation of micronutrients and arginine. However, two studies [10, 11] 
were uncontrolled and the micronutrient status in plasma/serum was not 
investigated.  
Besides inflammation, the relatively short period of the supplementation in our 
study (CHAPTER TWO) may be the reason for stable nutrient concentration in 
plasma/serum. In a recent study, van Anholt et al. [9] investigated the effect of a 
daily high-dose supplementation of several micronutrients (714 mg vitamin A, 
750 mg vitamin C, 114 mg α-tocopherol equivalents, 27 mg zinc, 192 µg selenium, 
4.05 mg copper and 600 µg folic acid), 60 g protein and 9 g arginine for eight weeks 
versus placebo in non-malnourished patients with pressure ulcers stage III and IV. 
Interestingly, after intervention, an increase in plasma concentration of micro-
nutrients was only observed for ascorbic acid (P=0.015) in the verum group. In 
contrast to the interventional study (CHAPTER TWO), a higher dose of vitamin C 
(750 mg vs. 500 mg/d) and a longer period of intervention (eights vs. two weeks) 
were chosen. Since CRP concentrations remained unchanged in both groups, the 
nutrient concentration-lowering impact of the inflammation seems to dominate 
influence of dose and length of the supplementation. Nevertheless, the wound 
closed faster in the verum compared to the placebo group. Thus, beneficial effects 
on wound closure by supplementation of nutrients as observed in CHAPTER TWO 
without changes in plasma concentration of these nutrients are not a contradiction. 
Unfortunately, the mechanisms remain unclear due to our study design. An 
intracellular accumulation of micronutrients in the wounded area may provide an 
explanation for the accelerated WH. Thus, the analysis of intra-cellular 
concentrations may elucidate the destination of the ingested micronutrients which is 
only possible in animal studies due to ethical reasons. 
It is well-known that post-traumatic inflammation favours an imbalance 
between oxidants and antioxidants [12, 13], the so called oxidative stress. After 
injury, neutrophils and macrophages invade the wounded tissue to phagocytize 
debris and to kill microorganisms by respiratory burst and releasing reactive oxygen 
species (ROS) [14-16]. Furthermore, ROS act as a second messenger to gene 
expression of various growth factors that induce VEGF expressions in keratinocytes, 
and activate the gene expression of collagenase that helps in the degradation of 
extracellular matrix [17]. Macrophages, fibroblasts and endothelial cells also express 
inducible nitric oxide synthase that produces nitric oxide to kill microbials and to 
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support collagen synthesis and angiogenesis, respectively. Thus, oxidative stress is 
important for proper WH. However, ROS may also impair WH [18]. Non-healing 
wounds remain in the inflammatory phase without transition to tissue formation. The 
reason may be inactivation of epidermal enzymatic antioxidants due to oxidative 
stress that prolongs the inflammatory phase [16]. Thus, excessive oxidative stress is 
assumed to delay wound healing [16, 18, 19]. Unfortunately, the threshold between 
physiologic and pathologic oxidative stress is still unknown. Since direct 
measurements of ROS were impossible, indirect parameters like peroxides, MDA 
and 8-isoprostanes were used to determine oxidative stress in the present studies 
(see CHAPTER ONE: Table 4, discussion section, and CHAPTER TWO: Table 6). 
Interestingly, these parameters were elevated in patients with DWH and TEAC was 
lower in all patients compared to healthy volunteers in both present studies 
(CHAPTER ONE: Table 4, and CHAPTER TWO: discussion section and Table 6). Hence, 
an imbalance between antioxidants and oxidants can strongly be assumed in our 
patients and may favour DWH. 8-isoprostanes decreased after intervention that 
indicated a reduction of oxidative stress and may have favoured the WH in the 
verum group (CHAPTER TWO: Table 6). However, MDA, peroxides, and TEAC did not 
change. This effect may be due to the still present inflammation and the relatively 
short period between the analyses of these parameters.  
Interestingly, none of the patients with RWH had vascular diseases and 
infections compared to patients with DWH (CHAPTER ONE (Table 1)) whereas the 
prevalence for patients without soft tissue trauma were even higher in patients with 
DWH. Infections and vascular diseases are linked to each other since a decreased 
microcirculation in the wound area limits the wound healing by diminished local 
perfusion [20] and oxygenation of the tissue. Thus, local bacterial growth is favoured 
by local hypoxia and diminished supply of nutrients and vice versa in terms of a 
vicious circle [21] and occur obviously in all types of wound irrespective from the 
severity of (soft tissue) trauma (CHAPTER ONE and TWO: Table1, ever). Oxygenation 
is also connected to the formation of new vessels [22] as an increased oxygenation 
enhanced the VEGF concentration in the wound fluid [23]. Unfortunately, no 
changes of the O2 saturation and VEGF concentrations were observed even though 
time to wound closure was shorter in patients with DWH who received micronutrients 
and glutamine (CHAPTER TWO, Figure 1). As discussed in CHAPTER TWO, these 
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findings are not a contradiction as the measurement of the microcirculation by O2C 
and the analysis of VEGF-A in serum did not necessarily mirror local angiogenesis.   
Although the general nutritional status was not associated with WH in our 
study patients probably due to a small proportion of undernourished patients and 
short observation time, anthropometric parameters should be evaluated regularly.  
As a consequence of our and former study results in patients with DWH and 
pressure ulcers [24], a tailored nutritional therapy with several micronutrients and a 
diet with adequate amounts of protein and energy should be implemented regularly 
in the medical treatment Furthermore, to ensure the comprehension of clinical 
nutrition and to create awareness for nutrition-associated illnesses and 
comorbidities, seminars in nutritional physiology and clinical nutrition should be 
integrated in the physicians´ education. Shang et al. [25] demonstrated that nutrition 
support teams in hospitals consisting of physicians, nutritional scientist, dieticians, 
nurses, and pharmacologists are an excellent mechanism for identifying patients in 
need of nutrition support. Thus, the formation and establishing of these teams is 
highly desirable for improving the efficacy of nutrition support in a clinical setting.  
In conclusion, the results of the cross-sectional and interventional study 
(CHAPTER ONE and TWO) do not show associations between the micronutrient 
concentrations in plasma/serum, parameters of oxidative stress and the wound 
healing of trauma patients with DWH. However, the nutritional status in 
plasma/serum has to be evaluated cautiously due to post-traumatic inflammation 
which lowers micronutrient concentrations directly or indirectly by reduced availability 
of transporter proteins. Moreover, the micronutrient concentrations in the wound may 
be more decisive for WH than those concentrations in plasma/serum. Since the 
supplementation of micronutrients and glutamine accelerated WH, tailored nutritional 
measures contribute effectively to wound treatment and, thus, should be 
implemented in daily clinical routine.   
 
 
.  
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ANNEX 69
 
ANNEX A: Questionnaire of the studies 
 
Studie „Ernährungsstatus u. Wundheilung“ Proband Nr.    
 
Datum Trauma/OP                              _ _ . _ _ . 20_ _ 
 
Datum der Untersuchung _ _ . _ _ . 20_ _ 
 
Geschlecht   männlich   weiblich 
Geburtsdatum _ _ . _ _ . _ _ _ _  
Alter (Jahre) _ _ 
Raucher   ja    nein 
Supplementierung (Vitamine u.a.)   ja    nein 
 Wenn ja, welche? (evtl. Präparat, Dosis) 
                                                             ___________________________________________ 
 
Medikamente: 
Cortison                                                                               ja             nein 
Zytostatika                                                                           ja   nein 
 
Erkrankungen/Beschwerden 
1) Diabetes mellitus: Typ 1                                                  ja   nein 
                                  Typ 2                                                  ja   nein 
   Insulinpflicht:                                                                     ja   nein 
 
   Genetische Disposition für Diab. mellitus Typ II ?   ja   nein   
 
2) Gastrointestinale Erkrankungen   ja   nein 
 
Wenn ja, welche:    _____________________________________________ 
 
Gastrointestinale Beschwerden (nach Eingriff)  ja   nein 
(Appetitlosigkeit, Durchfall, Schmerzen) 
 
3) Atopische Dermatitis                                   ja   nein 
4) Hypertonie                                                                         ja   nein 
5) Patient mobil   ja   nein 
6) Gefäßerkrankungen                                   ja   nein
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ggf. pAVK nach Fontaine                                 I                  II              III                 IV 
 
7) Patient  dement:                                    ja   nein 
              
8) Karnofsky-Index:                                                                  __________________                      
 
Sonstige Erkrankungen 
 
 
 
Dekubitus                                                                           ja             nein 
(nicht als Primärdiagnose) 
 
Anthropometrische Daten 
 
Gewicht ______,___ kg 
Größe ______,___ cm 
BMI (kg/m2) _______ 
 
 
Umfangmessungen 
Umfang Hüfte (HU) ____,__ cm ____,__ cm 
Umfang Taille (TU) ____,__ cm ____,__ cm 
Waist-to-hip-Ratio (TU [cm]:HU [cm]) _______ 
Wadenumfang  ____,__ cm ____,__ cm 
Oberarmumfang ____,__ cm ____,__ cm 
Trizepshautfaltendicke ____,__ cm ____,__ cm ____,__ cm 
 
 
Bioelektrische Impedanzanalyse 
 
Frequenz 
(kHz) 
R 
(Ohm) 
Xc 
(Ohm) 
s R tot 
(Ohm) 
alpha 
(Grad) 
R Hand 
(Ohm) 
R Fuß 
(Ohm) 
 50        
       5        
 
ANNEX 
 
71
ANNEX B: Nutritional Risk Screening 
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ANNEX C: Subjective Global Assessment  
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